$23,000+ Per Month in Revenue Opportunities Identified in the 2026 Ketamine Clinic Intelligence Report
We analyzed 23,496 ketamine treatment inquiries, mapped 1,473 clinic locations across all 50 states, and reviewed public pricing from 132 clinic websites. Then we built a single dashboard that answers the question every clinic owner is actually asking: where is the money I’m leaving on the table?
The answer, on average: $23,000 or more per month — per practice.
That’s what we found when we ran the numbers for a clinic treating 50 patients per month. The quickest opportunities are in pricing adjustments, billing optimization, and retention revenue increases you can implement before adding a single new patient.
The Three Fastest Revenue Opportunities
The report’s Revenue tab maps every monetizable opportunity by implementation timeline and effort level. The three that move the needle fastest:
- Pricing is wrong at most clinics. After benchmarking 132 clinic websites against regional market data, the majority of clinics are priced 15–25% below what patients in their geography are willing to pay. A $25 price increase across 50 treatments per month adds $1,250–$2,500/month — before any new marketing or new patients.
- Billing codes worth thousands per month are going unused. Time-based documentation, modifier stacking, neurocognitive testing reimbursements, and psychotherapy add-ons are underutilized across the industry. Most clinics are leaving $2,000+ per month on the table in reimbursable services they’re already providing.
- Retention math is being ignored. The average induction patient generates $2,100 in lifetime value. A patient on a three-year maintenance protocol generates $9,300–$14,700. The difference is a single conversation — and most clinics are not having it systematically.
What Else Is in the Report
Revenue is one of nine tabs in the 2026 Ketamine Clinic Intelligence Report. The full dashboard also covers:
- Patients — condition breakdown, urgency signals, inquiry timing, and price expectations from 23,496 real patient submissions. (More than 23% of inquiries arrive between midnight and 6 a.m. Most clinics respond only during business hours.)
- Growth — ancillary service analysis, peptide therapy, neurocognitive testing, IV wellness, and the LTV math behind patient retention programs.
- Treatments — IV vs. IM vs. Spravato pricing by region, revenue per 100 patients by modality, and the complete Spravato business case (including the 12-session protocol and reimbursement structure).
- Marketing — SEO benchmarks, keyword data, and an AEO playbook for getting your clinic to appear in ChatGPT, Perplexity, and Google AI Overviews. Includes anonymized profiles of three high-performing clinics.
- Market — CDC depression prevalence vs. clinic density by county, state regulatory timelines, and demographic targeting data.
- Actions — a prioritized, numbered action plan with estimated revenue impact for each recommendation, organized by what to do first.
Built From Six Years of First-Party Data
HealingMaps has operated the largest directory of ketamine and psychedelic therapy providers in the United States since 2019. The 2026 report is the first time that operational intelligence has been made available to practitioners directly.
The dataset behind the report:
- 23,496 ketamine treatment inquiries (filtered from 85,000+ total platform submissions)
- 1,473 clinic locations mapped across all 50 states
- 132 clinic websites analyzed for pricing, services, SEO, and digital presence
- CDC PLACES 2023 county-level depression prevalence data
- A 14-clinic practitioner survey on operations, billing, and pain points
Who This Is For
This report is written for clinic owners and operators — not patients. It assumes clinical knowledge and focuses entirely on business intelligence. It is particularly useful for:
- Clinics that have been operating for 1–3 years and want to benchmark against the industry
- Practitioners considering adding Spravato, peptide therapy, TMS, or neurocognitive testing
- Owners evaluating a second location and wanting market data before committing
- Any clinic that has not formally reviewed its pricing against regional benchmarks in the past 12 months
Pricing and Access
The report is available for $199. Permanent access to this edition — no subscription, no annual renewal.
